Aggarwal R, Starodub AN, Koh BD, Xing G, et al. Phase 1b Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res 2022 Jul 11. pii: 706956. doi: 10.1158/1078-0432.CCR-22-0175.
PMID: 35816286